Gene therapy with mRNA is more cost-efficient, has a better safety profile, and is more reproducible than the viral vector, AAV, currently used for gene therapy to improve inherited retinal diseases.
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 13,950,000 shares, a growth of 42.9% from the October 31st total of 9,760,000 shares. Based on an average daily trading volume, of 2,490,000 shares, the short-interest ratio is […]
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of complex bone infections.
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration RoslinCT will.
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.